Sign in

CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company

CERENOME, INC.

Sign in to watch
Ticker
CNSY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330827593
Phone
737.255.7194
Business address
6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
Former names
PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 37 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2004-11-18 CALHOUN CHRISTOPHER J Chief Executive Officer Sale −50,000 $3.00 $150K 100,000
2004-06-08 CALHOUN CHRISTOPHER J Chief Executive Officer Sale −150,000 $3.79 $569K 150,000
2004-06-02 HOLMES E CARMACK Director Grant or award · Employee Stock Options (Right to Buy) +35,000 85,000
2004-06-02 COX MARSHALL G Director Grant or award · Employee Stock Option (Right to Buy) +50,000 406,876
2004-06-02 GALETTO CHARLES Sr Vice President Finance Grant or award · Employee Stock Option (Right to Buy) +25,000 210,000
2004-06-02 REUTER BRUCE Sr Vice Pres Business Devel Grant or award · Employee Stock Options (Rights to Buy) +25,000 225,000
2004-06-02 SCARBROUGH ELIZABETH Vice President Marketing Devel Grant or award · Employee Stock Options (Rights to Buy) +25,000 106,250
2004-06-02 SCHULZKI SHARON Chief Operating Officer Grant or award · Employee Stock Options (Rights to Buy) +50,000 310,000

Page 53 of 53 · 1,048 trades